About SingVax
SingVax is a Healthcare company based in Singapore (Singapore) founded in 2004, and was acquired by Inviragen in October 2009. Prophylactic vaccines for infectious diseases. The company was acqui-hired. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is SINGVAX PTE. LTD.
Company details
SingVax was established in 2004 in Singapore within the biotechnology sector. Focus was placed on developing prophylactic vaccines targeting infectious diseases, with product candidates including an Enterovirus 71 vaccine to prevent hand, foot, and mouth disease in children, a Japanese Encephalitis vaccine against JE virus infection, and a chikungunya virus vaccine. Operations centered on vaccine research and development. Acquisition by Inviragen occurred in October 2009.
- Headquarters Singapore, Singapore
- Stage Acquired
- SectorsHealthcare
- Website singvax.com
- Acquired by Inviragen (Oct 2009)
- Legal Name Singvax Pte. Ltd.
Investors in SingVax
SingVax has secured backing from 1 investor. Prominent investors backing the company include Inviragen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vaccines for infectious diseases including dengue and influenza were developed. | 2005 | inviragen.com | Fort Collins, United States |
Investor details for SingVax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SingVax
2 dated milestones of SingVax across 5 years, from founding to its latest funding, stage changes and deals.
- Founded SingVax is founded.
- Exit Acquired by Inviragen.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SingVax
SingVax was founded in 2004.
SingVax is headquartered in Singapore, Singapore.
SingVax was established in 2004 in Singapore within the biotechnology sector. Focus was placed on developing prophylactic vaccines targeting infectious diseases, with product candidates including an Enterovirus 71 vaccine to prevent hand, foot, and mouth disease in children, a Japanese Encephalitis vaccine against JE virus infection, and a chikungunya virus vaccine. Operations centered on vaccine research and development. Acquisition by Inviragen occurred in October 2009.
SingVax has 1 investor. Key investors include Inviragen.
SingVax operates through Singvax Pte. Ltd..
Yes. SingVax was acquired by Inviragen in October 2009.